Related Experiment Video
Updated: Jan 17, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
772
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2024 Trainee Symposium
Clementina López-Medina1, Michelle Mulder2, Lihi Eder3
1C. López-Medina, MD, PhD, Department of Rheumatology, Reina Sofia University Hospital, IMIBIC, University of Cordoba, Cordoba, Spain.
The Journal of Rheumatology
|September 15, 2025
Summary
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) trainee symposium highlighted cutting-edge research in psoriatic diseases. The event showcased advancements across basic, translational, and clinical studies, emphasizing GRAPPA
Area of Science:
- Dermatology and Rheumatology research focused on psoriatic diseases.
Background:
- The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) convenes globally to advance understanding of psoriatic diseases.
- Trainee research is crucial for fostering innovation and future leadership in the field.
Purpose of the Study:
- To summarize key findings presented at the GRAPPA 2024 annual meeting trainee symposium.
- To highlight the breadth of research conducted by emerging dermatology and rheumatology professionals in psoriatic diseases.
Main Methods:
- Review of 5 oral presentations and 16 posters from the GRAPPA 2024 trainee symposium.
- Categorization of research into basic, translational, clinical, and outcomes domains.
Main Results:
- Exceptional research by dermatology and rheumatology trainees was showcased.
- Presentations covered diverse aspects of psoriatic diseases, from fundamental science to patient outcomes.
- The symposium demonstrated GRAPPA's commitment to nurturing talent and disseminating new knowledge.
Conclusions:
- The GRAPPA 2024 trainee symposium successfully highlighted significant advancements in psoriatic disease research.
- The event underscored the global impact and collaborative nature of GRAPPA's efforts in advancing scientific understanding and clinical practice.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248
01:21EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364
01:29Chronic Pancreatitis II: Collaborative Care
315
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
315
01:30Peripheral Artery Disease I: Introduction
314
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
314
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K